Imax says it’s open to a sale. Why is no one buying?

by | Sep 5, 2026 | Business

Imax says it's open to a sale. Why is no one buying?

Imax Chief Executive Rich Gelfond signaled openness to a potential sale in December, but the company has not attracted serious acquisition interest in the months since. The company conducted preliminary discussions with potential buyers earlier in the year but had not received formal offers as of May. Imax has not engaged investment bankers or prepared a formal sales pitch book, according to reports.

The lack of bidders comes despite strong operational momentum. Imax achieved an all-time high stock price and set records in box office performance. The company posted global ticket sales exceeding $400 million for “The Odyssey,” representing nearly 30% of that film’s total global sales despite Imax screens accounting for less than 1% of all movie screens globally. Analysts project the company will set a new annual box office record in 2026. Premium ticket pricing has not deterred audiences, with average adult Imax tickets in the United States reaching $20.57, compared to $12.75 for standard screenings.

Several structural factors may explain the lack of acquisition interest. Major Hollywood studios including Disney, Universal, Paramount, and Warner Bros. would face conflicts of interest, as analysts noted Imax maintains studio-agnostic pricing and must maintain relationships across the industry to fill a 52-week theatrical calendar. Few studios have pursued cinema ownership even after regulatory restrictions were lifted, with Sony being the notable exception through its acquisition of Alamo Drafthouse locations in 2024.

Tech and streaming companies could represent alternative buyers. Netflix has recently developed an appetite for acquisitions, though its traditional reluctance toward theatrical releases presents complications. Apple, Amazon, and Sony have also been mentioned as potential suitors. Any acquisition would require balancing Imax’s established studio partnerships and cinema relationships while navigating regulatory scrutiny and industry dynamics that have historically limited studio involvement in exhibition.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI